Skip to content

ELECTROMEDICAL TECHNOLOGIES, INC.: 10-Q filed 2020-11-16

What ELECTROMEDICAL TECHNOLOGIES, INC. reported in its quarterly report filed 2020-11-16 (fiscal Q3 2020): 38 published measures, 108 facts as tagged in accession 0001104659-20-125911.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-16
Fiscal period
fiscal Q3 2020
Accession
0001104659-20-125911 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ELECTROMEDICAL TECHNOLOGIES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-301,214,898USD
At 2019-12-31902,866USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-302,099,069USD
At 2019-12-313,087,303USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-30-884,171USD
At 2020-06-30-2,380,686USD
At 2020-03-31-2,333,061USD
At 2019-12-31-2,184,437USD
At 2019-09-30-2,391,440USD
At 2019-06-30-2,293,438USD
At 2019-03-31-2,143,564USD
At 2018-12-31-2,060,240USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-09-3085,477USD
At 2019-12-310USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,169,983USD92
2020-01-01 to 2020-09-30-3,461,479USD274
2020-04-01 to 2020-06-30-840,255USD91
2020-01-01 to 2020-03-31-451,241USD91
2019-07-01 to 2019-09-30-190,630USD92
2019-01-01 to 2019-09-30-1,231,017USD273
2019-04-01 to 2019-06-30-221,418USD91
2019-01-01 to 2019-03-31-818,969USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30795,644USD274
2019-01-01 to 2019-09-30187,547USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-07-01 to 2020-09-30205,850USD92
2020-01-01 to 2020-09-30557,476USD274
2019-07-01 to 2019-09-30270,128USD92
2019-01-01 to 2019-09-30625,020USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-30881,121USD274
2019-01-01 to 2019-09-30187,547USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-8,714,180USD
At 2019-12-31-5,252,701USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-30754,688USD
At 2019-12-31771,094USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-09-302,761,848USD274
2019-01-01 to 2019-09-30754,317USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-2,094,910USD92
2020-01-01 to 2020-09-30-3,350,612USD274
2019-07-01 to 2019-09-30-178,476USD92
2019-01-01 to 2019-09-30-1,154,418USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-30374,609USD
At 2019-12-31106,192USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-07-01 to 2020-09-3052,658USD92
2020-01-01 to 2020-09-3082,168USD274
2019-07-01 to 2019-09-3010,601USD92
2019-01-01 to 2019-09-3035,342USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-301,372,081USD
At 2019-12-312,296,591USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-30308,198USD
At 2019-12-31251,162USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-3016,841USD
At 2019-12-3115,667USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-3062,500USD
At 2019-12-3124,694USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-30148,467USD92
2020-01-01 to 2020-09-30417,584USD274
2019-07-01 to 2019-09-30194,926USD92
2019-01-01 to 2019-09-30443,611USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-07-01 to 2020-09-3057,383USD92
2020-01-01 to 2020-09-30139,892USD274
2019-07-01 to 2019-09-3075,202USD92
2019-01-01 to 2019-09-30181,409USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-07-01 to 2020-09-302,243,377USD92
2020-01-01 to 2020-09-303,768,196USD274
2019-07-01 to 2019-09-30373,402USD92
2019-01-01 to 2019-09-301,598,029USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-07-01 to 2020-09-300USD92
2020-01-01 to 2020-09-300USD274
2019-07-01 to 2019-09-3014,529USD92
2019-01-01 to 2019-09-3035,610USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3028,810,348shares
At 2019-12-3117,900,639shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-09-3085,477USD
At 2019-12-310USD
At 2019-09-300USD
At 2018-12-310USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-09-307,474,723USD
At 2019-12-312,713,087USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-09-30899,987USD
At 2019-12-31899,987USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-09-30145,299USD
At 2019-12-31128,893USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-09-3085,601USD
At 2019-12-3125,580USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2020-09-3018,794USD
At 2019-12-3111,306USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-30209,791USD
At 2019-12-3165,831USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2020-09-3064,780USD
At 2019-12-3140,120USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-07-01 to 2020-09-305,468USD92
2020-01-01 to 2020-09-3016,406USD274
2019-07-01 to 2019-09-305,468USD92
2019-01-01 to 2019-09-3018,988USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-75,073USD92
2020-01-01 to 2020-09-30-110,867USD274
2019-07-01 to 2019-09-30-12,154USD92
2019-01-01 to 2019-09-30-76,599USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-09-3037,408USD274
2019-01-01 to 2019-09-3014,805USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-01-01 to 2020-09-3050,000USD274
2019-01-01 to 2019-09-30110,000USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-304,939USD274
2019-01-01 to 2019-09-302,239USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-3037,806USD274
2019-01-01 to 2019-09-3029,847USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-3057,036USD274
2019-01-01 to 2019-09-3082,434USD273

Inspect the source

Entity
ELECTROMEDICAL TECHNOLOGIES, INC. / CIK 0001715819
Captured
2026-09-21T17:24:36.315Z
SEC response SHA-256
2ad8df4a9c5fb16e050ace525a2934e53474d15f46925e8496da9b3607574d0f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001715819.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))